Screener
Climb Bio, Inc. CLYM Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 447 | 505 |
| Property and equipment, net | 250 | 288 |
| Other long-term assets | 1,530 | 1,530 |
| Total assets | $152,372 | $167,744 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $860 | $2,269 |
| Accrued expenses and other current liabilities | 2,948 | 4,459 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s total assets?
- Climb Bio, Inc. (CLYM) reported total assets of $152.37M in Q1 2026.
- How has Climb Bio, Inc.'s total assets changed year-over-year?
- Climb Bio, Inc.'s total assets decreased by 24.1% year-over-year, from $200.74M to $152.37M.
- What is the long-term trend for Climb Bio, Inc.'s total assets?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s total assets has grown at a 46.8% compound annual growth rate (CAGR), from $24.63M to $167.74M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Climb Bio, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude